Back to Journals » Patient Preference and Adherence » Volume 17

The Medication Use Issues and Challenges of Mental Illness Exacerbation in Patients with Schizophrenia: A Qualitative Study in Thailand [Letter]

Authors Siahaya GC, Herwawan JH, Tasijawa FA 

Received 3 December 2023

Accepted for publication 6 December 2023

Published 7 December 2023 Volume 2023:17 Pages 3205—3206

DOI https://doi.org/10.2147/PPA.S453030

Checked for plagiarism Yes

Editor who approved publication: Dr Jongwha Chang



Griennasty Clawdya Siahaya, Joan Herly Herwawan, Fandro Armando Tasijawa

Faculty of Health, Universitas Kristen Indonesia Maluku, Maluku Province, Indonesia

Correspondence: Fandro Armando Tasijawa, Faculty of Health, Universitas Kristen Indonesia Maluku, Maluku Province, Indonesia, Email [email protected]


View the original paper by Mr Klinpiboon and colleagues

A Response to Letter has been published for this article.


Dear editor

The article titled “The Medication Use Issues and Challenges of Mental Illness Exacerbation in Patients with Schizophrenia: A Qualitative Study in Thailand”1 offers a compelling viewpoint. This study demonstrated a crucial discovery that adherence to medicine is the principal determinant of preventing relapses in patients with schizophrenia. This was due to medication alleviating symptoms, fostering positive thinking, and enhancing productivity. Furthermore, the study also holds practical implications for the social milieu in improving the quality of life of schizophrenia patients, mitigating symptom occurrence, and curbing hospital readmissions. This study significantly contributes to the enhanced mental health service and fosters a supportive social environment for patients with schizophrenia in Thailand.

Nevertheless, the study possessed several restrictions, including1 Methodology restrictions; the research spanned a lengthy period of one year and relied on the input of merely five crucial informants. The reason for the extended duration of this research has yet to be explained. Furthermore, there needs to be more clarity regarding the number of comprehensive interviews conducted, the identity of the interviewers, the language employed, and the level of rigour and trustworthiness.2 Cultural restrictions arise due to the informants’ characteristics not being representative of the population in terms of gender, age, education, marital status, and substance addiction. Hence, the findings and recommendations may exclusively pertain to specific cultural, religious, and social situations.2 In order to tackle this problem, forthcoming studies should focus on enhancing the methodology, such as refining recruitment techniques and increasing the sample size to encompass a broader spectrum of cultural, religious, and socioeconomic viewpoints. In addition, they clearly and explicitly emphasise the need for rigour and trustworthiness in qualitative research. By incorporating these recommendations, research can surmount methodological and cultural constraints and offer a comprehensive perspective on medication adherence by gathering data from different cultural, religious, and social backgrounds.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Klinpiboon P, Chanthapasa K. The medication use issues and challenges of mental illness exacerbation in patients with schizophrenia: a qualitative study in Thailand. Patient Prefer Adherence. 2023;17:2927–2937. doi:10.2147/PPA.S420973

2. Chiappini S, Di Carlo F, Mosca A, et al. Efficacy of psychosocial and psychological interventions in addition to drug therapy to improve global functioning of inpatients with schizophrenia spectrum and mood disorders: a real-world observational study. Neuropsychiatr Dis Treat. 2023;19:1887–1897. doi:10.2147/NDT.S418627

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.